XML 48 R32.htm IDEA: XBRL DOCUMENT
v3.19.2

Earnings Per Share (Tables) | 12 Months Ended
--- | ---
Jun. 29, 2019
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share | The following table sets forth the computation of basic and diluted net (loss) income per share (in millions, except per share data):
| Years Ended
| June 29, 2019 |  | June 30, 2018 |  | July 1, 2017
Numerator: |  |  |  |  |  |  |  |
Income (loss) from continuing operations, net of taxes | $ | 7.8 |  |  | $ | (48.6 | ) |  | $ | 158.6 |
(Loss) income from discontinued operations, net of taxes | (2.4 | ) |  | — |  |  | 1.6 |
Net income (loss) | $ | 5.4 |  |  | $ | (48.6 | ) |  | $ | 160.2 |
Denominator: |  |  |  |  |
Weighted-average shares outstanding: |  |  |  |  |
Basic | 228.1 |  |  | 227.1 |  |  | 229.9 |
Effect of dilutive securities from stock-based benefit plans | 3.1 |  |  | — |  |  | 4.6 |
Diluted | 231.2 |  |  | 227.1 |  |  | 234.5 |
Net income (loss) per share from - basic: |  |  |  |  |
Continuing operations | $ | 0.03 |  |  | $ | (0.21 | ) |  | $ | 0.69 |
Discontinued operations | (0.01 | ) |  | — |  |  | 0.01 |
Net income (loss) | $ | 0.02 |  |  | $ | (0.21 | ) |  | $ | 0.70 |
Net income (loss) per share from - diluted: |  |  |  |  |
Continuing operations | $ | 0.03 |  |  | $ | (0.21 | ) |  | $ | 0.68 |
Discontinued operations | (0.01 | ) |  | — |  |  | — |
Net income (loss) | $ | 0.02 |  |  | $ | (0.21 | ) |  | $ | 0.68 |
Schedule of Antidilutive Securities | The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):
| Years Ended
| June 29, 2019 (2)(3)(4) |  | June 30, 2018 (1)(2)(3)(4) |  | July 1, 2017 (2)(3)
Stock options and ESPP | 0.1 |  |  | 1.6 |  |  | 0.9 |
Full Value Awards | 0.4 |  |  | 7.3 |  |  | 0.6 |
Total potentially dilutive securities | 0.5 |  |  | 8.9 |  |  | 1.5 |
(1) | As the Company incurred a net loss from continuing operations in the period, potential dilutive securities from employee stock options, ESPP, RSUs and PSUs have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.
(2) | The Company’s 0.625% Senior Convertible Notes due 2033 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. In October 2018, the 2033 Notes were fully redeemed and any potential dilution effect of the Notes was realized upon the Company settling the “in-the-money” conversion benefit feature of the Notes with shares of common stock. Refer to “Note 11. Debt” for more details.
(3) | The Company’s 1.00% Senior Convertible Notes due 2024 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $13.22 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 11. Debt” for more details.
(4) The Company’s 1.75% Senior Convertible Notes due 2023 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $13.94 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 11. Debt” for more details.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration